Different cross protection scopes of two avian influenza H5N1 vaccines against infection of layer chickens with a heterologous highly pathogenic virus.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsPoetri, Okti Nadia
Van Boven, Michiel
Wayan Wisaksana, I
MetadataShow full item record
TitleDifferent cross protection scopes of two avian influenza H5N1 vaccines against infection of layer chickens with a heterologous highly pathogenic virus.
Published inRes Vet Sci 2017; 114:143-52
PubliekssamenvattingAvian influenza (AI) virus strains vary in antigenicity, and antigenic differences between circulating field virus and vaccine virus will affect the effectiveness of vaccination of poultry. Antigenic relatedness can be assessed by measuring serological cross-reactivity using haemagglutination inhibition (HI) tests. Our study aims to determine the relation between antigenic relatedness expressed by the Archetti-Horsfall ratio, and reduction of virus transmission of highly pathogenic H5N1 AI strains among vaccinated layers. Two vaccines were examined, derived from H5N1 AI virus strains A/Ck/WJava/Sukabumi/006/2008 and A/Ck/CJava/Karanganyar/051/2009. Transmission experiments were carried out in four vaccine and two control groups, with six sets of 16 specified pathogen free (SPF) layer chickens. Birds were vaccinated at 4weeks of age with one strain and challenge-infected with the homologous or heterologous strain at 8weeks of age. No transmission or virus shedding occurred in groups challenged with the homologous strain. In the group vaccinated with the Karanganyar strain, high cross-HI responses were observed, and no transmission of the Sukabumi strain occurred. However, in the group vaccinated with the Sukabumi strain, cross-HI titres were low, virus shedding was not reduced, and multiple transmissions to contact birds were observed. This study showed large differences in cross-protection of two vaccines based on two different highly pathogenic H5N1 virus strains. This implies that extrapolation of in vitro data to clinical protection and reduction of virus transmission might not be straightforward.
- Silent spread of highly pathogenic Avian Influenza H5N1 virus amongst vaccinated commercial layers.
- Authors: Poetri ON, Van Boven M, Claassen I, Koch G, Wibawan IW, Stegeman A, Van den Broek J, Bouma A
- Issue date: 2014 Dec
- Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
- Authors: Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y
- Issue date: 2015 Feb 25
- Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
- Authors: Connie Leung YH, Luk G, Sia SF, Wu YO, Ho CK, Chow KC, Tang SC, Guan Y, Malik Peiris JS
- Issue date: 2013 Aug 2
- Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
- Authors: Jadhao SJ, Lee CW, Sylte M, Suarez DL
- Issue date: 2009 Oct 19
- Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals.
- Authors: Swayne DE, Avellaneda G, Mickle TR, Pritchard N, Cruz J, Bublot M
- Issue date: 2007 Sep